文献速递中药与中成药合理使用中医内科

氨溴索在大鼠血液与脑中的游离药物药代动力学及与远志的相互作用

Protein unbound pharmacokinetics of ambroxol in the blood and brains of rats and the interaction of ambroxol with Polygala tenuifolia by multiple microdialysis.
PubMed 文献 · J Ethnopharmacol · 2020-12-28

本研究采用多微透析联用UPLC-MS/MS法,在大鼠中测定氨溴索在血液和脑纹状体的游离药物浓度,并评估远志提取物对氨溴索药代动力学的影响。结果显示氨溴索易透过血脑屏障,脑渗透率约30-34%,AUC随剂量线性增加;远志提取物(1 g/kg灌胃5天)未显著改变氨溴索在血液和脑中的药代动力学。

要点

  • 氨溴索低、高剂量(10、30 mg/kg iv)后约60 min纹状体达峰,AUC随剂量线性增加。
  • 氨溴索脑渗透率约为30-34%(AUCbrain/AUCblood)。
  • 远志提取物(1 g/kg po×5天)未显著改变氨溴索血/脑药代动力学。

核心结论

  • 该给药方案下远志提取物与氨溴索合用无药代动力学相互作用,提示安全性。

研究设计与样本

  • 大鼠分三组:低剂量氨溴索单用(10 mg/kg iv)、高剂量氨溴索单用(30 mg/kg iv)、氨溴索(10 mg/kg iv)预给远志提取物(1 g/kg po连续5天)。
  • 采用多微透析系统联用验证的UPLC-MS/MS法测定大鼠血液和脑样品。

主要发现

  • 氨溴索易穿透入脑,低和高剂量给药后约60 min纹状体达最大浓度。
  • 10和30 mg/kg剂量下AUC比值成比例增加,提示氨溴索呈线性药代动力学。
  • 氨溴索脑渗透率约为30-34%,定义为AUCbrain/AUCblood。
  • 远志提取物未显著改变氨溴索在大鼠血液和脑中的药代动力学。

临床怎么用

  • 在所述剂量方案下,远志提取物与氨溴索联用未观察到显著药代动力学相互作用,可为临床合用提供参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Ambroxol elevates glucocerebrosidase (GCase) activity and reduces nigrostriatal alpha-synuclein burden to better ameliorate motor function in Parkinson's disease (PD). Polygala tenuifolia is a potential alternative botanical medicine for the treatment of many nonmotor symptoms of PD commonly used in Taiwanese patients. Co-administration of these two medicines pose potential herb-drug interaction. AIM OF THE STUDY: Our hypothesis is that ambroxol and P. tenuifolia may potentially possess herbal drug synergetic effects in the blood and brain. MATERIALS AND METHODS: To investigate this hypothesis, a multiple microdialysis system coupled with validated ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method was developed for rat blood and brain samples. Experimental rats were divided into three groups: low-dose and high-dose ambroxol alone (10 mg/kg, i.v. and 30 mg/kg, i.v., respectively) and ambroxol (10 mg/kg, i.v.) pretreated with P. tenuifolia extract (1 g/kg, p.o. for 5 consecutive days). RESULTS: Ambroxol easily penetrated into the brain and reached a maximum concentration in the striatum at approximately 60 min after low- and high-dose treatment. The area under the concentration curve (AUC) ratio increased proportionally at the doses of 10 and 30 mg/kg, which suggested a linear pharmacokinetic manner of ambroxol. The brain penetration of ambroxol was approximately 30-34%, which was defined as the ambroxol AUC blood-to-brain distribution ratio (AUCbrain/AUCblood). The P. tenuifolia extract did not significantly alter the pharmacokinetics of ambroxol in the blood and brain of rats. CONCLUSION: The present study suggests that it is safety without pharmacokinetic interactions for this dosing regimen to use P. tenuifolia extract and ambroxol together.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Yang CN, Peng WY, Lin LC, et al. Protein unbound pharmacokinetics of ambroxol in the blood and brains of rats and the interaction of ambroxol with Polygala tenuifolia by multiple microdialysis. J Ethnopharmacol. 2020. PMID: 33383115. doi:10.1016/j.jep.2020.113764

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。